Bluejay Diagnostics (BJDX) Profit After Tax Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 99.26% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 4.70% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 125.69% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -27.13% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 51.30% |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | -2.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.94% |
| Dec 31, 2025 | 0.15% |
| Sep 30, 2025 | -7.81% |
| Jun 30, 2025 | 20.96% |
| Mar 31, 2025 | 19.93% |
| Dec 31, 2024 | 37.81% |
| Sep 30, 2024 | 35.51% |
| Jun 30, 2024 | 12.01% |
| Mar 31, 2024 | 8.32% |
| Dec 31, 2023 | 3.50% |
| Sep 30, 2023 | 22.36% |
| Jun 30, 2023 | -45.21% |
| Mar 31, 2023 | -26.15% |
| Dec 31, 2022 | -63.39% |
| Sep 30, 2022 | -148.03% |
| Jun 30, 2022 | -402.61% |
| Mar 31, 2022 | -936.83% |
| Dec 31, 2021 | -168.46% |
| Sep 30, 2021 | -832.42% |